Can a Calf CBD Half-Life Predict Human Exposure?

forensic toxicology working group members October 28, 2026 Forensic Toxicology

A CBD half-life measured in dairy calves cannot set a human detection window. A seven-calf study found slow absorption and prolonged apparent elimination, but those estimates describe a particular species, age group, product and sampling design.

What was measured

Seven young male Holstein calves received a single oral CBD-oil dose of 5 mg/kg. Blood was collected over 48 hours, and CBD was quantified in bovine plasma with chromatographic mass spectrometry.

The geometric mean peak concentration was approximately 0.05 micrograms/mL, reached around 7.5 hours. The reported geometric mean half-life was approximately 23 hours. These are summaries of plasma pharmacokinetics, not behavioral or therapeutic endpoints.

Why the study cannot establish effectiveness

The experiment describes how CBD entered and left the measured compartment. It did not establish pain relief, improved welfare or another clinical benefit. Nor did it determine tissue-residue depletion sufficiently to create a food-safety withdrawal interval.

A single oral route also cannot by itself establish absolute bioavailability. That requires an appropriate reference exposure, usually an intravenous comparison, rather than assuming all of the administered amount reached circulation.

Limits on transferring the number

Young calves differ from adult cattle, dogs and humans in physiology and feeding. The limited sample and 48-hour collection period also constrain estimates of variability and the late concentration-time curve. A reported half-life is a model-dependent estimate, not a deadline after which every specimen becomes negative.

The research received funding from Panacea Life Sciences, and an author was affiliated with that company. For a human forensic question, these findings are background animal evidence rather than a substitute for validated human, matrix-specific data.